Cannabis-Related Securities | Quarterly Update | Fourth Quarter 2023
The CRB Monitor Securities Research team covers all aspects of the publicly-traded cannabis ecosystem, including the regulatory environment, operational expansion/M&A... Read more.
Cannabis-Related Securities | Monthly Update | December 2023
December 2023 provided, if nothing else, a ray of hope for those investors that have stuck around for the duration of this performance history that boasts all the... Read more.
Cannabis-Related Securities | Monthly Update | November 2023
November 2023 had cannabis investors saying, “Well, at least it didn’t tank again”. In fact, they were treated to returns that reflected either 1) optimism... Read more.
Cannabis-Related Securities | Monthly Update | October 2023
October 2023 saw precious little support for cannabis equities (see above), and many CRBs returned to their pre-HHS rescheduling announcement lows. We are all old... Read more.
Cannabis-Related Securities Quarterly Update | Third Quarter 2023
The CRB Monitor Securities Research team covers all aspects of the publicly-traded cannabis ecosystem, including the regulatory environment, operational expansion/M&A... Read more.
Cannabis-Related Securities Monthly Update | September 2023
With the hysteria over The announcement that the US Department of Health and Human Services recommended rescheduling cannabis to Schedule III from Schedule I now... Read more.
CRB Monitor Chart of the Month | September 2023
This month we take a closer look at the near-term health of the largest 20 pure play Tier 1 CRBs, as we consider what investors have to look forward to given the... Read more.
